Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
20.51
+0.41 (2.04%)
Sep 2, 2026, 10:06 AM EDT - Market open

Syndax Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Syndax Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $37.55. The average 1-year stock price forecast is 83.08% higher than the current stock price, while the lowest is $26 (+26.77%) and the highest is $57 (+177.91%).

Price Target: $37.55 (+83.08%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$26$37.55$37$57
Change+26.77%+83.08%+80.40%+177.91%

Analyst Ratings

The average analyst rating for Syndax Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy111111111010
Buy222222
Hold000000
Sell000000
Strong Sell000000
Total131313131212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Buy
Reiterates
$37$33
BuyReiterates$37$33+60.90%Aug 21, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$40
BuyMaintains$40+95.03%Aug 14, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
$44$40
BuyMaintains$44$40+95.03%Aug 11, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
$26
BuyMaintains$26+26.77%Aug 5, 2026
Citi
Citi
Buy
Maintains
$57
BuyMaintains$57+177.91%Aug 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
316.10M
from 172.35M
Increased by 83.40%
Revenue Next Year
463.08M
from 316.10M
Increased by 46.50%
EPS This Year
-1.93
from -3.29
EPS Next Year
-0.82
from -1.93
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
139.71M--23.68M172.35M316.10M
Revenue Growth
9,109.56%---627.84%83.40%
Operating Income
26.22M-151.76M-229.95M-339.67M-273.08M-145.40M
Net Income
24.93M-149.34M-209.36M-318.76M-285.42M-179.66M
EPS
-----3.29-1.93
Free Cash Flow
32.03M-76.27M-82.37M-155.26M-209.80M-34.20M
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High334.9M
Avg316.1M
Low303.6M

Revenue Growth

Revenue Growth202620272028
High
94.3%
Avg
83.4%
Low
76.2%

EPS Forecast

EPS202620272028
High-1.65
Avg-1.93
Low-2.25

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-